@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ns1: <http://purl.org/spar/pro/> .
@prefix ns2: <http://purl.org/vocab/frbr/core#> .
@prefix ns3: <http://purl.org/spar/datacite/> .
@prefix ns4: <http://prismstandard.org/namespaces/basic/2.0/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<> dcterms:license <https://creativecommons.org/publicdomain/zero/1.0/legalcode> .

<https://w3id.org/oc/meta/br/06220974746> a <http://purl.org/spar/fabio/Expression>,
        <http://purl.org/spar/fabio/JournalArticle> ;
    rdfs:label "br 06220974746" ;
    ns4:publicationDate "2017-04"^^xsd:gYearMonth ;
    dcterms:title "Neuronal And Molecular Effects Of Cannabidiol On The Mesolimbic Dopamine System: Implications For Novel Schizophrenia Treatments" ;
    ns3:hasIdentifier <https://w3id.org/oc/meta/id/062201031436>,
        <https://w3id.org/oc/meta/id/06470689556>,
        <https://w3id.org/oc/meta/id/06604103524> ;
    ns1:isDocumentContextFor <https://w3id.org/oc/meta/ar/062204204736>,
        <https://w3id.org/oc/meta/ar/062204204737>,
        <https://w3id.org/oc/meta/ar/062204204738>,
        <https://w3id.org/oc/meta/ar/062204204739>,
        <https://w3id.org/oc/meta/ar/062204204740> ;
    ns2:embodiment <https://w3id.org/oc/meta/re/06220767195> ;
    ns2:partOf <https://w3id.org/oc/meta/br/06220975345> .